Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Chinese Drugmakers Gain After Reports of Tick Deaths, Superbug

Chinese drugmakers rose to the highest in four months after Xinhua News reported deaths in China’s central Henan province from tick-borne disease and a Health Ministry alert against a drug-resistant bacteria.

Shandong Lukang Pharmaceutical Co., a Chinese antibiotic maker, jumped by the 10 percent daily limit in Shanghai as of 10:01 a.m. local time. North China Pharmaceutical Co. climbed 5.2 percent to 11.18 yuan, the biggest increase since May 27.

A measure of healthcare-related stocks had the biggest gain among the 10 industry groups on the CSI 300 Index and rose to the highest since April 27. The benchmark Shanghai Composite Index slid 0.4 percent to 2,685.48.

“The tick deaths certainly provided a trigger for today’s gains in healthcare stocks, which may benefit from increased demand,” said Liu Bin, Shanghai-based analyst at Guoyuan Securities Co., in a phone interview.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.